STAT

Opinion: STAT+: A bold approach to pay for weight loss drugs for everyone who needs them

A bold idea for how to pay for weight loss drugs for everyone who needs them — and save Medicare at the same time.
Source: Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, added cardiovascular benefit to value in combating obesity and diabetes. This comes on to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readChemistry
STAT+: Pharmalittle: We’re Reading About Fake Studies, AbbVie Investing In Psychedelics, And More
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost revenue.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks